Stockscreener 앱 받기
0.4596
0.35%
-0.0016
시장 영업 전:
.44
-0.0196
-4.26%
전일 마감가:
$0.4612
열려 있는:
$0.4655
하루 거래량:
1.36M
Relative Volume:
0.10
시가총액:
$67.73M
수익:
-
순이익/손실:
$-54.17M
주가수익비율:
-1.2425
EPS:
-0.3699
순현금흐름:
$-39.34M
1주 성능:
-5.70%
1개월 성능:
+27.14%
6개월 성능:
-73.59%
1년 성능:
-81.54%
1일 변동 폭
$0.454
$0.4698
1주일 범위
$0.427
$0.489
52주 변동 폭
$0.2928
$3.5299
Immutep Limited Adr Stock (IMMP) Company Profile
Compare IMMP vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMMP
Immutep Limited Adr
|
0.4596 | 67.73M | 0 | -54.17M | -39.34M | -0.3699 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Immutep Limited Adr Stock (IMMP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-13 | 다운그레이드 | Citizens | Mkt Outperform → Mkt Perform |
| 2026-03-13 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2026-03-13 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2026-02-17 | 개시 | Citizens | Mkt Outperform |
| 2024-05-17 | 개시 | CapitalOne | Overweight |
| 2023-08-03 | 개시 | Robert W. Baird | Outperform |
| 2021-08-03 | 개시 | Ladenburg Thalmann | Buy |
| 2021-07-16 | 재개 | Maxim Group | Buy |
| 2018-09-28 | 개시 | B. Riley FBR | Buy |
| 2018-02-15 | 재확인 | Maxim Group | Buy |
모두보기
Immutep Limited Adr 주식(IMMP)의 최신 뉴스
Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action InvestigationIMMP - ChartMill
IMMP Investor News: If You Have Suffered Losses in Immutep Ltd. (NASDAQ: IMMP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
IMMP Stock Price, Quote & Chart | IMMUTEP LTD-SP ADR (NASDAQ:IMMP) - ChartMill
IMMP Forecast, Price Target & Analyst Ratings | IMMUTEP LTD-SP ADR (NASDAQ:IMMP) - ChartMill
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Immutep Ltd. Investors to Inquire About Securities Class Action InvestigationIMMP - TMX Newsfile
ROSEN, A LEADING LAW FIRM, Encourages Immutep Ltd. Investors to Inquire About Securities Class Action InvestigationIMMP - TMX Newsfile
ROSEN, LEADING INVESTOR COUNSEL, Encourages Immutep Ltd. Investors to Inquire About Securities Class Action InvestigationIMMP - TMX Newsfile
Immutep Announces Abstract Accepted for Presentation at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting - Sahm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immutep LimitedIMMP - ChartMill
Immutep LTD ADR (IMMP) News, Articles, Events & Latest Updates - Stocktwits
IMMP Investor Alert: Immutep Ltd. Securities Fraud InvestigationInvestors With Losses May Seek to Lead the Class Action After Company Allegedly Failed To Disclose Material Risks Related To Trial Viability : Levi & Korsinsky - Sahm
Nasdaq Surges 200 Points; Morgan Stanley Posts Upbeat Earnings - Sahm
Dow Gains 100 Points; Bank of America Earnings Top Views - Sahm
US Market Preview | IMMP Surges 200%; Trump on Iran War: 'Close to Over'; Tesla AI5 Chip Tapped Out; ASML Falls 3% After Weak Q2 Outlook - Sahm
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.15% - Investing.com
These stocks are moving in today's session - ChartMill
Which stocks are most active on Wednesday? - ChartMill
Here are the top movers in Wednesday's session. - ChartMill
These stocks are moving in today's pre-market session - ChartMill
Immutep Receives FDA Orphan Drug Designation for Eftilagimod Alfa in Soft Tissue Sarcoma - ChartMill
Working capital per share of Immutep Ltd Sponsored ADR – FWB:YP1A - TradingView — Track All Markets
IMMP Investor News: If You Have Suffered Losses in Immutep - GlobeNewswire
ROSEN, A NATIONALLY RECOGNIZED INVESTOR RIGHTS LAW FIRM, Encourages Immutep Ltd. Investors to Inquire About Securities Class Action InvestigationIMMP - TMX Newsfile
POM IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages PomDoctor Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action - GlobeNewswire Inc.
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Immutep Ltd. Investors to Inquire About Securities Class Action InvestigationIMMP - TMX Newsfile
IMMP Investors Have Opportunity to Join Immutep Limited Fraud Investigation with the Schall Law Firm - Business Wire
Immutep (NASDAQ: IMMP) reports positive Phase I progress for LAG-3 agonist IMP761 - Stock Titan
On Wednesday, there are stocks with unusual volume. Let's take a look. - ChartMill
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Immutep Limited (IMMP) And Encourages Investors to Reach Out - accessnewswire.com
Immutep Limited Adr (IMMP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):